This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Love, R. A.
Right arrow Articles by Fuhrman, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Love, R. A.
Right arrow Articles by Fuhrman, S. A.

 Previous Article  |  Next Article 

Journal of Virology, July 2003, p. 7575-7581, Vol. 77, No. 13
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.13.7575-7581.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Crystallographic Identification of a Noncompetitive Inhibitor Binding Site on the Hepatitis C Virus NS5B RNA Polymerase Enzyme

Robert A. Love,* Hans E. Parge, Xiu Yu, Michael J. Hickey, Wade Diehl, Jingjin Gao, Hilary Wriggers, Anne Ekker, Liann Wang, James A. Thomson, Peter S. Dragovich, and Shella A. Fuhrman

Pfizer Global Research and Development, La Jolla Laboratories, San Diego, California 92121

Received 14 January 2003/ Accepted 2 April 2003

The virus-encoded nonstructural protein 5B (NS5B) of hepatitis C virus (HCV) is an RNA-dependent RNA polymerase and is absolutely required for replication of the virus. NS5B exhibits significant differences from cellular polymerases and therefore has become an attractive target for anti-HCV therapy. Using a high-throughput screen, we discovered a novel NS5B inhibitor that binds to the enzyme noncompetitively with respect to nucleotide substrates. Here we report the crystal structure of NS5B complexed with this small molecule inhibitor. Unexpectedly, the inhibitor is bound within a narrow cleft on the protein's surface in the "thumb" domain, about 30 Å from the enzyme's catalytic center. The interaction between this inhibitor and NS5B occurs without dramatic changes to the structure of the protein, and sequence analysis suggests that the binding site is conserved across known HCV genotypes. Possible mechanisms of inhibition include perturbation of protein dynamics, interference with RNA binding, and disruption of enzyme oligomerization.

* Corresponding author. Mailing address: Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Dr., San Diego, CA 92121. Phone: (858) 622-7600. Fax: (858) 678-8156. E-mail: robert.love{at}pfizer.com.

Journal of Virology, July 2003, p. 7575-7581, Vol. 77, No. 13
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.13.7575-7581.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Shi, S. T., Herlihy, K. J., Graham, J. P., Nonomiya, J., Rahavendran, S. V., Skor, H., Irvine, R., Binford, S., Tatlock, J., Li, H., Gonzalez, J., Linton, A., Patick, A. K., Lewis, C. (2009). Preclinical Characterization of PF-00868554, a Potent Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase. Antimicrob. Agents Chemother. 53: 2544-2552 [Abstract] [Full Text]  
  • Carroll, S. S., Ludmerer, S., Handt, L., Koeplinger, K., Zhang, N. R., Graham, D., Davies, M.-E., MacCoss, M., Hazuda, D., Olsen, D. B. (2009). Robust Antiviral Efficacy upon Administration of a Nucleoside Analog to Hepatitis C Virus-Infected Chimpanzees. Antimicrob. Agents Chemother. 53: 926-934 [Abstract] [Full Text]  
  • Hass, M., Lelke, M., Busch, C., Becker-Ziaja, B., Gunther, S. (2008). Mutational Evidence for a Structural Model of the Lassa Virus RNA Polymerase Domain and Identification of Two Residues, Gly1394 and Asp1395, That Are Critical for Transcription but Not Replication of the Genome. J. Virol. 82: 10207-10217 [Abstract] [Full Text]  
  • Herlihy, K. J., Graham, J. P., Kumpf, R., Patick, A. K., Duggal, R., Shi, S. T. (2008). Development of Intergenotypic Chimeric Replicons To Determine the Broad-Spectrum Antiviral Activities of Hepatitis C Virus Polymerase Inhibitors. Antimicrob. Agents Chemother. 52: 3523-3531 [Abstract] [Full Text]  
  • Howe, A. Y. M., Cheng, H., Johann, S., Mullen, S., Chunduru, S. K., Young, D. C., Bard, J., Chopra, R., Krishnamurthy, G., Mansour, T., O'Connell, J. (2008). Molecular Mechanism of Hepatitis C Virus Replicon Variants with Reduced Susceptibility to a Benzofuran Inhibitor, HCV-796. Antimicrob. Agents Chemother. 52: 3327-3338 [Abstract] [Full Text]  
  • Nikonov, A., Juronen, E., Ustav, M. (2008). Functional Characterization of Fingers Subdomain-specific Monoclonal Antibodies Inhibiting the Hepatitis C Virus RNA-dependent RNA Polymerase. J. Biol. Chem. 283: 24089-24102 [Abstract] [Full Text]  
  • Kaushik-Basu, N., Bopda-Waffo, A., Talele, T. T., Basu, A., Costa, P. R. R., da Silva, A. J. M., Sarafianos, S. G., Noel, F. (2008). Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors. Nucleic Acids Res 36: 1482-1496 [Abstract] [Full Text]  
  • Shi, S. T., Herlihy, K. J., Graham, J. P., Fuhrman, S. A., Doan, C., Parge, H., Hickey, M., Gao, J., Yu, X., Chau, F., Gonzalez, J., Li, H., Lewis, C., Patick, A. K., Duggal, R. (2008). In Vitro Resistance Study of AG-021541, a Novel Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase. Antimicrob. Agents Chemother. 52: 675-683 [Abstract] [Full Text]  
  • Pauwels, F., Mostmans, W., Quirynen, L. M. M., van der Helm, L., Boutton, C. W., Rueff, A.-S., Cleiren, E., Raboisson, P., Surleraux, D., Nyanguile, O., Simmen, K. A. (2007). Binding-Site Identification and Genotypic Profiling of Hepatitis C Virus Polymerase Inhibitors. J. Virol. 81: 6909-6919 [Abstract] [Full Text]  
  • Hao, W., Herlihy, K. J., Zhang, N. J., Fuhrman, S. A., Doan, C., Patick, A. K., Duggal, R. (2007). Development of a Novel Dicistronic Reporter-Selectable Hepatitis C Virus Replicon Suitable for High-Throughput Inhibitor Screening. Antimicrob. Agents Chemother. 51: 95-102 [Abstract] [Full Text]  
  • Howe, A. Y. M., Cheng, H., Thompson, I., Chunduru, S. K., Herrmann, S., O'Connell, J., Agarwal, A., Chopra, R., Del Vecchio, A. M. (2006). Molecular Mechanism of a Thumb Domain Hepatitis C Virus Nonnucleoside RNA-Dependent RNA Polymerase Inhibitor. Antimicrob. Agents Chemother. 50: 4103-4113 [Abstract] [Full Text]  
  • Le Pogam, S., Kang, H., Harris, S. F., Leveque, V., Giannetti, A. M., Ali, S., Jiang, W.-R., Rajyaguru, S., Tavares, G., Oshiro, C., Hendricks, T., Klumpp, K., Symons, J., Browner, M. F., Cammack, N., Najera, I. (2006). Selection and Characterization of Replicon Variants Dually Resistant to Thumb- and Palm-Binding Nonnucleoside Polymerase Inhibitors of the Hepatitis C Virus.. J. Virol. 80: 6146-6154 [Abstract] [Full Text]  
  • Kukolj, G., McGibbon, G. A., McKercher, G., Marquis, M., Lefebvre, S., Thauvette, L., Gauthier, J., Goulet, S., Poupart, M.-A., Beaulieu, P. L. (2005). Binding Site Characterization and Resistance to a Class of Non-nucleoside Inhibitors of the Hepatitis C Virus NS5B Polymerase. J. Biol. Chem. 280: 39260-39267 [Abstract] [Full Text]  
  • Mo, H., Lu, L., Pilot-Matias, T., Pithawalla, R., Mondal, R., Masse, S., Dekhtyar, T., Ng, T., Koev, G., Stoll, V., Stewart, K. D., Pratt, J., Donner, P., Rockway, T., Maring, C., Molla, A. (2005). Mutations Conferring Resistance to a Hepatitis C Virus (HCV) RNA-Dependent RNA Polymerase Inhibitor Alone or in Combination with an HCV Serine Protease Inhibitor In Vitro. Antimicrob. Agents Chemother. 49: 4305-4314 [Abstract] [Full Text]  
  • Di Marco, S., Volpari, C., Tomei, L., Altamura, S., Harper, S., Narjes, F., Koch, U., Rowley, M., De Francesco, R., Migliaccio, G., Carfi, A. (2005). Interdomain Communication in Hepatitis C Virus Polymerase Abolished by Small Molecule Inhibitors Bound to a Novel Allosteric Site. J. Biol. Chem. 280: 29765-29770 [Abstract] [Full Text]  
  • Biswal, B. K., Cherney, M. M., Wang, M., Chan, L., Yannopoulos, C. G., Bilimoria, D., Nicolas, O., Bedard, J., James, M. N. G. (2005). Crystal Structures of the RNA-dependent RNA Polymerase Genotype 2a of Hepatitis C Virus Reveal Two Conformations and Suggest Mechanisms of Inhibition by Non-nucleoside Inhibitors. J. Biol. Chem. 280: 18202-18210 [Abstract] [Full Text]  
  • Tomassini, J. E., Getty, K., Stahlhut, M. W., Shim, S., Bhat, B., Eldrup, A. B., Prakash, T. P., Carroll, S. S., Flores, O., MacCoss, M., McMasters, D. R., Migliaccio, G., Olsen, D. B. (2005). Inhibitory Effect of 2'-Substituted Nucleosides on Hepatitis C Virus Replication Correlates with Metabolic Properties in Replicon Cells. Antimicrob. Agents Chemother. 49: 2050-2058 [Abstract] [Full Text]  
  • Ludmerer, S. W., Graham, D. J., Boots, E., Murray, E. M., Simcoe, A., Markel, E. J., Grobler, J. A., Flores, O. A., Olsen, D. B., Hazuda, D. J., LaFemina, R. L. (2005). Replication Fitness and NS5B Drug Sensitivity of Diverse Hepatitis C Virus Isolates Characterized by Using a Transient Replication Assay. Antimicrob. Agents Chemother. 49: 2059-2069 [Abstract] [Full Text]  
  • McKercher, G., Beaulieu, P. L., Lamarre, D., LaPlante, S., Lefebvre, S., Pellerin, C., Thauvette, L., Kukolj, G. (2004). Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate. Nucleic Acids Res 32: 422-431 [Abstract] [Full Text]  
  • Tomei, L., Altamura, S., Bartholomew, L., Bisbocci, M., Bailey, C., Bosserman, M., Cellucci, A., Forte, E., Incitti, I., Orsatti, L., Koch, U., De Francesco, R., Olsen, D. B., Carroll, S. S., Migliaccio, G. (2004). Characterization of the Inhibition of Hepatitis C Virus RNA Replication by Nonnucleosides. J. Virol. 78: 938-946 [Abstract] [Full Text]  
  • Xu, X., Liu, Y., Weiss, S., Arnold, E., Sarafianos, S. G., Ding, J. (2003). Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design. Nucleic Acids Res 31: 7117-7130 [Abstract] [Full Text]  
  • Tomei, L., Altamura, S., Bartholomew, L., Biroccio, A., Ceccacci, A., Pacini, L., Narjes, F., Gennari, N., Bisbocci, M., Incitti, I., Orsatti, L., Harper, S., Stansfield, I., Rowley, M., De Francesco, R., Migliaccio, G. (2003). Mechanism of Action and Antiviral Activity of Benzimidazole-Based Allosteric Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase. J. Virol. 77: 13225-13231 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»